Class Action Activity Roundup: Addressing The Latest and Greatest in Plaintiffs’ Bar Attacks on OTC Drug Products

January 24, 2024 8:30am

Andrew Soukup
Partner
Covington & Burling LLP

Stephen McConnell
Partner
Reed Smith LLP

  • Assessing the latest emerging OTC product liability and false advertising litigations and class action activity
  • Addressing the rising trend of consumer advocacy research labs (e.g. Valisure, Emery Pharma) performing their own testing on OTC products that are spawning product recalls and class litigations
    • Understanding the role of these consumer advocacy groups and their behind-the-scenes coordination with the plaintiffs’ bar
  • Navigating the unique challenges inherent to OTC product litigations, such as lack of prescriptions, receipts and written records of product use
  • Safeguarding your company and brand against the risk of false advertising /deception class actions